1. Gilbert DA, Altshuler KZ, Rago WV, et al. Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry 1998;59:345-51.
2. Altshuler KZ, Rush AJ. Computerized Texas Medication Algorithm Project undergoes testing. Outcomes Accountability Alert 1999;4(1):10-11.
3. Rush AJ, Crismon ML, Kashner TM, et al. Texas Medication Algorithm Project, Phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry 2003;64(4):357-69.
4. Altman E, Hedeker D, Janicak P, et al. The Clinician-Administered Rating Scale For Mania (CARS-M): development, reliability, and validity. Biol Psychiatry 1994;36:124-34.
5. Suppes T, Dennehy EB, Swann AC, et al. Report of the Texas consensus conference panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 2002;63:288-99.
6. Dennehy EB, Doyle K, Suppes T. The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting. Int Clin Psychopharmacol 2003;18(3):143-5.
7. Dilsaver SC, Swann AC, Shoaib AM, et al. The manic syndrome: factors which may predict a patient’s response to lithium, carbamazepine and valproate. J Psych Neurosci 1993;18:61-6.
8. Tohen M, Chengappa KNR, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59(1):62-9.
9. Emrich HM. Studies with oxcarbazepine (Trileptal) in acute mania. Int Clin Psychopharmacol 1990;190(5,suppl):83-8.
10. Vieta E, Parramon G, Padrell E, et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002;4(5):335-40.
11. Keck PE, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three week placebo-controlled, double-blinded randomized trial. Am J Psychiatry 2003;160(4):741-8.
12. Yatham LN, Grossman F, Augustyns I, et al. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blinded, randomised controlled trial. Br J Psychiatry 2003;182:141-7.
13. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159(7):1146-54.
14. Keck PE, Jr, Marcus R, Tourkodimitris S, et al. Aripiprazole study group. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160(9):1651-8.
15. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episode: a review of 50 years’ experience. Am J Psychiatry 1988;45:727-32.
16. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trail of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999;156(8):1164-9.
17. Guille C, Sachs G. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Prog Neuropsychopharmacol Biol Psychiatry 2002;26(6):1035-9.
18. Vieta E, Torrent C, Garcia-Ribas G, et al. Use of topiramate in treatment-resistant bipolar spectrum disorders. J Clin Psychopharmacol 2002;22(4):431-5.
19. Calabrese JR, Suppes T, Bowden CL, et al. A double blinded, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-50.
20. Calabrese JR, Bowden CL, Sachs GS, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64(9):1013-24.
21. Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacology 1999;19:427-34.
22. Shelton RC, Tollefson GD, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001;158:131-4.
23. Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder (comment). Arch Gen Psychiatry 2000;57:490-2.
24. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003;160:1252-62.
